A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism

Thrombosis Research

Volumn 129, Issue 1, 2012, Pages 22-27

  Rondina, Matthew T ^a   Wanner, Nathan ^a   Pendleton, Robert C ^a   Kraiss, Larry W ^a   Vinik, Russell ^a   Zimmerman, Guy A ^a   Heilbrun, Marta ^a   Hoffman, John M ^a   Morton, Kathryn A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer Screening; Cost Effectiveness; Early Detection of Cancer; FDG PET CT; Occult Malignancy; Venous Thromboembolism

Indexed keywords

BARIUM; FLUORODEOXYGLUCOSE F 18;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD CLOTTING TEST; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; MEDICARE; OCCULT CANCER; PANCREAS ADENOCARCINOMA; PHYSICAL EXAMINATION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REIMBURSEMENT; SINGLE BLIND PROCEDURE; SYMPTOM; THROMBOPHILIA TEST; VENOUS THROMBOEMBOLISM; WHOLE BODY CT; WHOLE BODY PET;

ADULT; AGED; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MALE; MASS SCREENING; MEDICARE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TIME FACTORS; UNITED STATES; UTAH; VENOUS THROMBOEMBOLISM; WHOLE BODY IMAGING;

EID: 84655169564     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.06.025     Document Type: Article

References (27)

1. M. Carrier, G. Le Gal, P.S. Wells, D. Fergusson, T. Ramsay, and M.A. Rodger Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 149 5 2008 323 333
2. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 23 Suppl. 1 2003 I17 I21
3. H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, and J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 25 2000 1846 1850 (Pubitemid 32104130)
4. H.T. Sorensen, L. Mellemkjaer, F.H. Steffensen, J.H. Olsen, and G.L. Nielsen The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism N Engl J Med 338 17 1998 1169 1173 (Pubitemid 28180744)
5. J. Cornuz, S.D. Pearson, M.A. Creager, E.F. Cook, and L. Goldman Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis Ann Intern Med 125 10 1996 785 793 (Pubitemid 126449715)
6. M. Monreal, A.W. Lensing, M.H. Prins, M. Bonet, J. Fernandez-Llamazares, and J. Muchart Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism J Thromb Haemost 2 6 2004 876 881 (Pubitemid 40185732)
7. M. Nordstrom, B. Lindblad, H. Anderson, D. Bergqvist, and T. Kjellstrom Deep venous thrombosis and occult malignancy: an epidemiological study BMJ 308 6933 1994 891 894
8. A. Piccioli, A.W. Lensing, M.H. Prins, A. Falanga, G.L. Scannapieco, and M. Ieran Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial J Thromb Haemost 2 6 2004 884 889 (Pubitemid 40185734)
9. F.F. Van Doormaal, W. Terpstra, R. Van Der Griend, M.H. Prins, M.R. Nijziel, and M.A. Van De Ree Is extensive screening for cancer in idiopathic venous thromboembolism warranted? J Thromb Haemost 9 1 2011 79 84
10. V. Rieu, S. Chanier, P. Philippe, and M. Ruivard Systematic screening for occult cancer in elderly patients with venous thromboembolism: a prospective study Intern Med J 41 11 2011 769 775
11. M. Din, H.M. Otten, A. Piccioli, A.W. Lensing, P. Prandoni, and H.R. Buller Decision analysis for cancer screening in idiopathic venous thromboembolism J Thromb Haemost 3 11 2005 2391 2396 (Pubitemid 41727152)
12. M.M. Beckers, J.F. Verzijlbergen, M.M. van Buul, M.H. Prins, and D.H. Biesma The potential role of positron emission tomography in the detection of occult cancer in 25 patients with venous thromboembolism Ann Oncol 19 6 2008 1203 1204 (Pubitemid 351796349)
13. Y.K. Chen, H.J. Ding, C.T. Su, Y.Y. Shen, L.K. Chen, and A.C. Liao Application of PET and PEt/CT imaging for cancer screening Anticancer Res 24 6 2004 4103 4108 (Pubitemid 40468714)
14. H. Schoder, and M. Gonen Screening for cancer with PET and PET/CT: potential and limitations J Nucl Med 48 Suppl. 1 2007 4S 18S (Pubitemid 47604938)
15. C. Sioka, A. Fotopoulos, and A.P. Kyritsis Paraneoplastic neurological syndromes and the role of PET imaging Oncology 78 2 2010 150 156
16. R.L. Wahl Principles of cancer imaging with fluorodeoxyglucose R.L. Wahl, J.W. Buchanan, Principles and Practice of Positron Emission Tomography 2002 Lippincott Williams & Wilkins Philadelphia 100 110
17. M.W. Saif, I. Tzannou, N. Makrilia, and K. Syrigos Role and cost effectiveness of PET/CT in management of patients with cancer Yale J Biol Med 83 2 2010 53 65
18. G. Brix, E.A. Nekolla, D. Nosske, and J. Griebel Risks and safety aspects related to PET/MR examinations Eur J Nucl Med Mol Imaging 36 Suppl. 1 2009 S131 S138
19. W.R. Hendee Estimation of radiation risks. BEIR V and its significance for medicine JAMA 268 5 1992 620 624
20. P.A. Kyrle, E. Minar, C. Bialonczyk, M. Hirschl, A. Weltermann, and S. Eichinger The risk of recurrent venous thromboembolism in men and women N Engl J Med 350 25 2004 2558 2563
21. C. Kearon, J.S. Ginsberg, M.J. Kovacs, D.R. Anderson, P. Wells, and J.A. Julian Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism N Engl J Med 349 7 2003 631 639 (Pubitemid 36975995)
22. C. Kearon, M. Gent, J. Hirsh, J. Weitz, M.J. Kovacs, and D.R. Anderson A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism N Engl J Med 340 12 1999 901 907 (Pubitemid 29141050)
23. M.T. Rondina, R.C. Pendleton, M. Wheeler, and G.M. Rodgers The treatment of venous thromboembolism in special populations Thromb Res 119 4 2007 391 402 (Pubitemid 46149896)
24. P. Hainaut, C. Jaumotte, D. Verhelst, P. Wallemacq, J.L. Gala, and E. Lavenne Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases Thromb Res 106 2 2002 121 125 (Pubitemid 35245235)
25. L.L. Berland, S.G. Silverman, R.M. Gore, W.W. Mayo-Smith, A.J. Megibow, and J. Yee Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee J Am Coll Radiol 7 10 2010 754 773
26. J.L. Wagner Cost-effectiveness of screening for common cancers Cancer Metastasis Rev 16 3-4 1997 281 294 (Pubitemid 27519636)
27. T.O. Tengs, M.E. Adams, J.S. Pliskin, D.G. Safran, J.E. Siegel, and M.C. Weinstein Five-hundred life-saving interventions and their cost-effectiveness Risk Anal 15 3 1995 369 390